ClassID:

109323

C12N2501/2308 - CPC Classification

Classification description:

Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines; Interleukins [IL] Interleukin-8 (IL-8)

Recent Application in this class:
#1
20250361278
2025-11-27

RECOMBINANT PRODUCTION OF GROWTH FACTORS IN ALGAE FOR CELL CULTURE APPLICATIONS

#2
20250325584
2025-10-23

CANCER-KILLING CELLS

#3
20250230404
2025-07-17

METHOD OF USING FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS TO INCREASE COLLAGEN AND ELASTIN IN HUMAN SKIN

#4
20240400982
2024-12-05

PRECURSORY REGULATORY CYTOTROPHOBLAST CELLS AND USES THEREOF

#5
20240368550
2024-11-07

METHODS FOR PRODUCING MATURE CHONDROCYTE AND COMPOSITION CONTAINING MATURE CHONDROCYTE

#6
20240352406
2024-10-24

BIOCOMPATIBLE CONDITIONED CELL MEDIUM COMPOSITIONS AND USES THEREOF

#7
20240252639
2024-08-01

COMPOSITIONS AND METHODS FOR PRODUCING AND USING CELL-BASED IMMUNOTHERAPIES TO TARGET TUMORS

#8
20240228953
2024-07-11

METHOD FOR PROMOTING PROLIFERATION AND PLURIPOTENCY FACTOR EXPRESSION OF STEM CELLS AND COMPOSITION PRODUCED USING THE SAME

#9
20240197776
2024-06-20

CANCER-KILLING CELLS

#10
20230346834
2023-11-02

CANCER-KILLING CELLS

#11
20230174941
2023-06-08

METHOD FOR PRODUCING MATURE ADIPOCYTE-CONTAINING COMPOSITION

#12
20220325236
2022-10-13

Biocompatible conditioned cell medium compositions and uses thereof

#13
20220033772
2022-02-03

FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS

#14
20210371819
2021-12-02

Method for generating human multipotent mammary stem cells from normal primary breast luminal cells

#15
20210355437
2021-11-18

FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS

#16
20210355436
2021-11-18

Precursory regulatory cytotrophoblast cells and uses thereof

#17
20210230540
2021-07-29

UMBILICAL CORD LINING STEM CELLS AND CONDITIONED MEDIA THEREOF

#18
20210189340
2021-06-24

Cancer-killing cells

#19
20200354672
2020-11-12

Precursory regulatory cytotrophoblast cells and uses thereof

#20
20200172864
2020-06-04

T Cell Expansion Method

#21
20200115683
2020-04-16

Method of preparing in vitro-matured human intestinal organoids and use thereof

#22
20200095539
2020-03-26

Biocompatible conditioned cell medium compositions and uses thereof

#23
20200087627
2020-03-19

METHODS OF EXTRACTING HEMATOPOIETIC CELLS FROM BONE MARROW EX VIVO

#24
20190314409
2019-10-17

Cancer-killing cells

#25
20190153396
2019-05-23

Chemically defined medium for the culture of cancer stem cell (CSC) containing cell populations

#26
20180371417
2018-12-27

Bovine serum composition and method for culturing cells using said bovine serum composition as additive

#27
20180305662
2018-10-25

Method for generating human multipotent mammary stem cells from normal primary breast luminal cells

#28
20180298328
2018-10-18

ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS

#29
20180265841
2018-09-20

Method for generating human multipotent mammary stem cells from normal primary breast luminal cells

#30
20170233697
2017-08-17

Composition and Methods of Using Umbilical Cord Lining Stem Cells

#31
20170226472
2017-08-10

CULTURE MEDIUM AND METHOD FOR ENRICHING AND MAINTAINING CANCER STEM CELLS (CSCS) USING SAID MEDIUM

#32
20170044494
2017-02-16

Method for inducing endodermal and mesodermal differentiation from human pluripotent stem cells by CXCR2 suppression

#33
20150315572
2015-11-05

RNA preparations comprising purified modified RNA for reprogramming cells